Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / KPTI - Karyopharm Therapeutics: Unjustified Sell-Off Provides An Opportunity To Reload My Position

KPTI - Karyopharm Therapeutics: Unjustified Sell-Off Provides An Opportunity To Reload My Position

Karyopharm Therapeutics Inc.
  • Karyopharm Therapeutics reported their Q3 earnings with a beat on revenue and a slight miss on EPS. The company revealed that XPOVIO is making inroads into multiple myeloma.
  • Despite the encouraging earnings, the ticker has been sucked into the small-cap sell-off. I am looking to take advantage of the discounted share price and reload my KPTI position.
  • I will review the company's Q3 earnings and will also highlight points that help bolster investor sentiment. In addition, I reveal my plans for accumulating KPTI as we leave 2021.

For further details see:

Karyopharm Therapeutics: Unjustified Sell-Off Provides An Opportunity To Reload My Position
Stock Information
Company Name: Karyopharm Therapeutics Inc.
Stock Symbol: KPTI
Market: NASDAQ
Website: karyopharm.com
Menu
KPTI KPTI Quote KPTI Short KPTI News KPTI Articles KPTI Message Board
Get KPTI Alerts

News, Short Squeeze, Breakout and More Instantly...